Vita Coco Insiders Are Selling Heavily as Stock Soars—Is the Herd Leaving Before the Music Stops?

The news is straightforward: veteran board member John Leahy is retiring after a five-year tenure. Leahy brings a deep CPG pedigree, having served as President and COO of Kind and President of Nature's Bounty, with a career spanning giants like Nestlé and Johnson & Johnson. On paper, it's a clean, non-event. But the real story is in the filings, not the press release.

The critical data point is a Form 4 filed just last week, on March 19, 2026. It shows a prior intended sale of restricted stock by an "insider." That's the kind of paperwork that signals a planned exit of equity, not just a retirement from a board seat. This isn't an isolated incident. Zooming out, the broader trend is stark: insiders have sold over $263 million in stock over the past 24 months.

So, what is the smart money doing? It's selling. While Leahy's departure is a neutral corporate event, the concurrent pattern of insider selling suggests a notable lack of alignment with the stock's recent surge. When seasoned executives and board members are consistently cashing out, it often means they see less value ahead than the market does. The skin in the game is being removed, even as the company's public narrative continues.

Skin in the Game: The CEO and COO's Track Record

The board shuffle is noise. The real signal comes from the people running the company. When the CEO and COO are moving their money, it tells you what the smart money believes about the stock's future.

The latest action is a planned sale by CEO Martin Roper. On April 7 and 8, 2026, he exercised options to acquire 25,000 shares each day, then immediately sold them. This is a textbook 10b5-1 plan, a pre-arranged sale designed to avoid accusations of insider trading. But the timing is telling. He sold the shares at prices around $50, just as the stock has been climbing. This isn't a panic sell; it's a calculated exit of equity, removing his skin in the game at a favorable price.

Zooming out, this isn't an isolated act. The broader trend is one of consistent selling. Over the past 24 months, insiders have sold $263 million in stock. That includes COO Jonathan Burth, who sold 700 shares in February 2025. These are the executives whose compensation and career success are directly tied to the company's performance. When they are consistently cashing out, it often signals they see less value ahead than the market does.

Yet, there is a large portion of the stock still held by those with skin in the game. Insiders collectively own 32.3% of the company. That's a significant stake. The question for investors is whether the remaining insiders are confident enough to hold, or if the recent sales by top officers are a warning that the herd is leaving. The CEO's recent planned sale, executed at a premium, is a clear signal that the smart money is taking profits now.

The Smart Money Question: Valuation and Catalysts

The stock has run. Vita Coco's shares are up 55% year-to-date and a stunning 290% over the last five years. That kind of rally has priced in a lot of optimism. The company now trades at nearly 47 times earnings, a premium that leaves no room for error. The bullish narrative is clear: the coconut water market is set to nearly double, growing from $4.43 billion in 2024 to $11.43 billion by 2030. Vita Coco is expected to keep growing at a mid-teens pace, with analysts projecting an additional $25 million in revenue for 2026.

But here's the rub for the smart money. When a stock trades at 47 times earnings, the market is betting that operational execution will be flawless. The company needs to maintain its current growth rates into 2026 to justify the valuation. Any stumble-a slowdown in the category, tougher comparisons, or margin pressure from tariffs and costs-could quickly deflate the premium.

That's where the insider filings become a critical watchpoint. While the market is looking ahead to a massive market expansion, the insiders are looking over their shoulders. The consistent selling over the past 24 months, including the CEO's recent planned exit, suggests a notable lack of alignment with the stock's lofty price. When the people who know the business best are cashing out, it often means they see less value ahead than the market does.

The catalyst for a thesis change is clear. For the stock to keep climbing, Vita Coco must prove it can outpace the high expectations already baked into its nearly 47x multiple. The smart money, by its actions, seems to be betting that the company will struggle to deliver. The bullish market expansion is real, but the valuation is not. The question now is whether the operational execution can match the hype, or if the insider selling is a warning that the herd is leaving before the music stops.